Manufacturing Roche commits $750m to double Oregon-based US manufacturing capacity Pharmaceutical TechnologyRoche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes - serving its pipeline and portfolio.Read full story pharminent August 21, 2026 (Last updated: September 1, 2026) Pharmaceutical Technology Roche’s Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio. Read full story Post navigation Previous: Regeneron’s Pasatru Wins Full FDA Approval for Ultra-Rare ‘Stone Man Disease’Next: How cost and perception could reshape the GLP-1 market Related Stories Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026 Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026
